Pharmalot… Pharmalittle… Stretch A Little
Make a commentBy Ed Silverman // October 18th, 2007 // 12:07 pm
Such a busy morning. Between earnings, layoffs, management changes and the FDA meeting about cough and cold meds for kids, we are having trouble catching our breath. And what will we do without Exubera? While we contemplate, here are a few stray items that are worth noting…
FDA Panel Reviews Pediatric Cough And Cold Medicines (Yahoo/AP)
Nektar Therapeutics Stock Dives As Pfizer Discontinues Exubera (Yahoo/Reuters)
InVentiv Health Loses Novartis Sales Contract (Yahoo/Reuters)
Vertex Stock Slides On News Of Schering-Plough Hep C Study (Bloomberg News)
Galencia To Pay $900M For Aspreva Pharmaceuticals (The Financial Post)